Finnegan attorney Bob Kramer will participate in the panel discussion “U.S. Patentable Subject Matter,” at Australia's Medtech Conference. The conference will examine the major factors in global medtech success, outline key commercial issues, and provide updates in the fields of IP, regulatory approvals, health economics, and sales networks. The conference will take place at the Adelaide Convention and Exhibition Center in Adelaide, Australia. For more information, or to register, please see the AusBiotech website.
Articles
How the Timing of Hypothetical Negotiation Can Lead to a Higher Premium for Exclusivity
December/January 2026
Articles
Standing to Sue for Patent Infringement: Where Do We Stand on the “Exclusionary Right” Requirement?
November/December 2025
Articles
Keeping Promises: Enforcement Strategies for Certification Marks in the United States
May/June 2025
Articles
Patent Law's On-Sale Bar and Commercial Exploitation by Suppliers and Third Parties
March 21, 2025
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.